Safety and effectiveness of a somatropin biosimilar in children requiring growth hormone treatment: second analysis of the PATRO Children study
Latest Information Update: 01 Jun 2022
At a glance
- Drugs Somatropin (Primary)
- Indications Dwarfism; Growth disorders; Prader-Willi syndrome; Short stature; Somatotropin deficiency; Turner's syndrome
- Focus Adverse reactions; Therapeutic Use
- Acronyms PATRO Children
Most Recent Events
- 01 Jun 2022 Results of an analysis compared the safety and effectiveness data from patients treated with recombinant human growth hormone (rhGH) in the USA versus other countries published in the European Journal of Pediatrics
- 03 Jul 2020 New trial record
- 15 Jun 2020 Results published in the Journal of Endocrinological Investigation